Drug
Xb010
Xb010: highest development phase Phase 1, developed by Exelixis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Exelixis
Trials
| Drug | Phase | Indication |
|---|---|---|
| XB010 NCT06545331 | Phase 1 | Locally Advanced or Metastatic Solid Tumors |
Latest
No recent events.
Follow Xb010 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.